Metamizole Sodium Bausch Health

Metamizole Sodium, the active ingredient in Metamizole Sodium Bausch Health, is a non‑opioid analgesic (pyrazolone) presented as an injectable solution for intramuscular or intravenous use. It is employed to manage acute moderate to severe pain, postoperative discomfort, fever, and visceral colic in adult patients.

GNH USA supplies Metamizole Sodium Bausch Health as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Metamizole Sodium is indicated for conditions involving pain and fever where rapid relief is required.

Acute moderate to severe pain: provides analgesia for sudden, intense pain episodes. Post‑operative pain: reduces discomfort following surgical procedures. Fever: lowers elevated body temperature associated with infection or inflammation. Colic and visceral pain: alleviates spasm‑related abdominal pain.

Metamizole Sodium may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Hypotension: transient drop in blood pressure after injection. - Dizziness or vertigo. - Nausea or vomiting. - Injection‑site pain or erythema. - Mild leukopenia: slight reduction in white blood cells.

Serious or Rare Side Effects: - Agranulocytosis: severe depletion of neutrophils, potentially life‑threatening. - Severe allergic reactions: anaphylaxis, bronchospasm. - Skin disorders: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: elevated liver enzymes. - Hemolytic anemia. - Renal impairment: acute kidney injury.

Before initiating therapy, clinicians should evaluate patient history and monitor relevant parameters.

Assess for blood dyscrasias: perform baseline and periodic complete blood counts. Monitor renal and hepatic function: adjust use if impairment is detected. Use caution in patients with hypertension or cardiovascular instability. Avoid in individuals with known hypersensitivity to pyrazolones. Administer under medical supervision: ensure appropriate monitoring during and after injection. Store at ambient temperature: keep in original packaging, protect from moisture and direct light.

Metamizole Sodium can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other myelosuppressive agents: heightened risk of severe blood cell depletion. - Drugs known to cause agranulocytosis (e.g., carbamazepine): additive risk.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): potential additive renal effects. - Diuretics: may exacerbate hypotension. - Corticosteroids: increased risk of gastrointestinal irritation. - ACE inhibitors: possible enhancement of hypotensive response.